Sharps Technology INC

SkyAI, Inc. announced its Board of Directors has unanimously rejected an unsolicited, non-binding proposal from Forward Industries, Inc. for a potential all-stock business combination.

SkyAI, Inc. (formerly Sharps Technology, Inc.) announced a strategic business transformation to an agentic finance platform focused on emerging markets, rebranding and changing its ticker symbol.

SkyAI, Inc. has formally appointed Arthur Levine as Chief Financial Officer, effective May 22, 2026.

Sharps Technology, Inc. announced the appointment of Arthur Levine as interim Chief Financial Officer, effective February 17, 2026, while the company searches for a permanent replacement.

Sharps Technology, Inc. announced a 90-day lock-up agreement with its Strategic Advisor, Sol Markets, signaling confidence in the company's future.

Sharps Technology, Inc. has adopted updated bylaws, a revised code of ethics, and new charters for its Audit, Compensation, and Nominating & Corporate Governance Committees, effective January 15, 2026, to enhance corporate governance and compliance.

Sharps Technology, Inc. has adopted a limited duration stockholder rights plan to protect shareholder interests.

Sharps Technology, Inc. announced a major strategic shift to a digital asset treasury focused on Solana, raising $411 million, while reporting a significant net loss for Q3 2025 and spinning off its medical device manufacturing.

Sharps Technology, Inc. reported its first revenue in Q2 2025, bolstered by a significant capital raise, but continues to face operational losses and going concern doubts.

Sharps Technology reports a net income of $1.9 million for the quarter ended March 31, 2025, driven by a fair market value adjustment on warrants and the closing of a $20 million equity offering.

Sharps Technology reported no revenue for the third quarter of 2024, alongside a net loss, while navigating ongoing legal issues and strategic shifts.

Sharps Technology reported its Q2 2024 results, showing a net loss and ongoing challenges with commercialization, while also highlighting strategic partnerships and a potential asset acquisition.

Sharps Technology, Inc. shifts its core strategy to a Solana-focused digital asset treasury, reporting a substantial net loss of $282.5 million for the fiscal year ended December 31, 2025.

Sharps Technology, Inc. files an amendment to its annual report on Form 10-K to include the company's Compensation Recovery Policy.

Sharps Technology reports a net loss for FY24, focuses on expanding production capacity, and anticipates potential revenue generation in the second half of 2025.

Sharps Technology, Inc., a medical device company focused on safety syringe technology, reported its full year 2023 results, highlighting strategic partnerships and ongoing efforts to commercialize its product lines.

FalconX Holdings Ltd and its affiliated entities reported significant changes in their beneficial ownership of Sharps Technology Inc. common stock and warrants, including both sales and an acquisition of pre-funded warrants.

Saba Capital Management, L.P. reported selling shares of Sharps Technology Inc., reducing its beneficial ownership to below 10%.

Saba Capital Management, a 10% owner of Sharps Technology Inc., reported selling 107,465 shares of common stock across two transactions in mid-January 2026.

Sharps Technology Inc.'s Chief Investment Officer, Zhang Yuwen, was granted 500,000 stock options under the 2025 Equity Incentive Plan.

Sharps Technology Director Timothy Ruemler sold 20,000 shares of common stock, inadvertently generating short-swing profits which he has returned to the company.

Sharps Technology Inc. Director Timothy Ruemler increased his direct ownership by purchasing 40,000 common shares and was granted 80,000 stock options.

Sharps Technology, Inc. is calling for shareholder support on key proposals for its 2025 Special Meeting, including the election of an independent director and warrant initiatives.

Sharps Technology, Inc. calls a Special Meeting to approve significant warrant issuances and a new director, signaling substantial dilution for existing shareholders.

Sharps Technology, Inc. files definitive proxy statement for its 2025 Annual Meeting, proposing a significant increase in authorized common stock and approval of a new equity incentive plan.

Sharps Technology, Inc. proposes a significant increase in authorized common stock to 500 million shares and seeks approval for a new equity incentive plan at its upcoming 2025 Annual Meeting.

Sharps Technology, Inc. announces its 2025 Annual Meeting of Stockholders, seeking approval for a significant increase in authorized common stock, a new equity incentive plan, and the election of directors.

Sharps Technology is urging shareholders to vote in favor of a reverse stock split to maintain its Nasdaq listing and avoid delisting to the OTC Markets.

Sharps Technology has filed an amendment to its registration statement to increase the amount of securities offered, aiming to raise additional capital.

Sharps Technology, Inc. files an amendment to its Form S-1 registration statement to update exhibit information related to warrants and other agreements.

Sharps Technology, Inc. has filed documents detailing the terms of Series A and B warrants for the purchase of common stock.

Sharps Technology aims to raise capital through a unit offering, including common stock and warrants, to fund working capital and repay debt.

Sharps Technology Inc. plans to offer up to 6,726,457 units, each including common stock and warrants, or pre-funded units as an alternative.

FalconX Holdings Limited and its affiliates have increased their beneficial ownership in Sharps Technology, Inc. to 16.5%, signaling active engagement in strategic direction.

FalconX Holdings Limited and its affiliates have significantly increased their beneficial ownership in Sharps Technology, Inc. to 20.0% through a $45.7 million private placement of common stock and warrants.

Saba Capital Management, L.P. and Boaz R. Weinstein have reported a 6.95% beneficial ownership stake in Sharps Technology, Inc. common stock and warrants.

Wei Zhu and affiliated entities have filed a Schedule 13G disclosing a 9.9% beneficial ownership stake in Sharps Technology, Inc.

Bastion Trading Limited, Bastion Holdings Limited, and Wei Zhu have disclosed a 9.9% beneficial ownership stake in Sharps Technology, Inc., totaling 3,615,046 shares.

Saba Capital Management and affiliates disclose a 9.99% passive beneficial ownership stake in Sharps Technology, Inc. common stock and warrants.

Saba Capital Management, L.P. and affiliates have disclosed a 10.46% beneficial ownership stake in Sharps Technology, Inc., primarily through common stock and warrants.

Saba Capital Management, L.P. and affiliates have disclosed a 5.93% beneficial ownership stake in Sharps Technology, Inc., comprising common stock and warrants.